Travere Therapeutics, Inc. · NASDAQ:TVTX
Calvin Sandra sold 5,375 Travere Therapeutics, Inc. shares (Form 4)
Traded Sep 15, 2026 · Filed Sep 17, 2026
On Sep 15, 2026, Calvin Sandra (SVP, CHIEF ACCOUNTING OFFICER) sold 5,375 Travere Therapeutics, Inc. shares at an average US$62.33 for US$335K under a trading plan, leaving 42,353 shares. Filed Sep 17, 2026 (Form 4).
- Sold
- 5,375 shares
- Price
- US$62.33 average (US$62.14 to US$63.66)
- Value
- US$335K
- Holding after
- 42,353 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- SVP, CHIEF ACCOUNTING OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Stock | Option exercise | 2,500 | US$27.50 | 44,853 | Direct |
| Sep 15, 2026 | Common Stock | Option exercise | 1,250 | US$22.40 | 46,103 | Direct |
| Sep 15, 2026 | Common Stock | Option exercise | 1,625 | US$20.46 | 47,728 | Direct |
| Sep 15, 2026 | Common Stock | Sale | 4,275 | US$62.14 | 43,453 | Direct |
| Sep 15, 2026 | Common Stock | Sale | 800 | US$62.85 | 42,653 | Direct |
| Sep 15, 2026 | Common Stock | Sale | 300 | US$63.66 | 42,353 | Direct |